Persistent Suppression of Ocular Neovascularization with Intravitreal Administration of AAVrh.10 Coding for Bevacizumab
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Persistent Suppression of Ocular Neovascularization with Intravitreal Administration of AAVrh.10 Coding for Bevacizumab
Authors
Keywords
-
Journal
HUMAN GENE THERAPY
Volume 22, Issue 12, Pages 1525-1535
Publisher
Mary Ann Liebert Inc
Online
2011-07-30
DOI
10.1089/hum.2011.090
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of proliferative diabetic retinopathy with anti-VEGF agents
- (2011) Aysha Salam et al. ACTA OPHTHALMOLOGICA
- Update on nonsurgical therapy for diabetic macular edema
- (2011) Andre J Witkin et al. CURRENT OPINION IN OPHTHALMOLOGY
- Comparison of Intravitreal Bevacizumab and Ranibizumab Treatment for Diabetic Macular Edema
- (2011) Banu Turgut Ozturk et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture
- (2011) J. Fernando Arevalo et al. Journal of Ophthalmology
- Treatment of diabetic retinopathy with anti-VEGF drugs
- (2010) Michael Waisbourd et al. ACTA OPHTHALMOLOGICA
- Persistent expression of biologically active anti-HER2 antibody by AAVrh.10-mediated gene transfer
- (2010) G Wang et al. CANCER GENE THERAPY
- Transduction of the inner mouse retina using AAVrh8 and AAVrh10 via intravitreal injection
- (2010) Thomas J. Giove et al. EXPERIMENTAL EYE RESEARCH
- A review of clinical trials of anti-VEGF agents for diabetic retinopathy
- (2010) Benjamin P. Nicholson et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Ocular Gene Therapy: An Evaluation of Recombinant Adeno-Associated Virus-Mediated Gene Therapy Interventions for the Treatment of Ocular Disease
- (2010) Kamolika Roy et al. HUMAN GENE THERAPY
- Preclinical Safety Evaluation of AAV2-sFLT01— A Gene Therapy for Age-related Macular Degeneration
- (2010) Timothy K MacLachlan et al. MOLECULAR THERAPY
- Inhibition of Choroidal Neovascularization in a Nonhuman Primate Model by Intravitreal Administration of an AAV2 Vector Expressing a Novel Anti-VEGF Molecule
- (2010) Michael Lukason et al. MOLECULAR THERAPY
- Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy
- (2010) Napoleone Ferrara NATURE MEDICINE
- Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration
- (2010) James C. Folk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
- (2010) Michael J. Elman et al. OPHTHALMOLOGY
- Efficacy and Safety of Monthly versus Quarterly Ranibizumab Treatment in Neovascular Age-related Macular Degeneration: The EXCITE Study
- (2010) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGY
- Intravitreal bevacizumab for persistent macular edema with proliferative diabetic retinopathy
- (2010) Gokhan Gulkilik et al. INTERNATIONAL OPHTHALMOLOGY
- Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials
- (2009) P Mitchell et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration
- (2009) Francesca Simonelli et al. MOLECULAR THERAPY
- Effects of Intraocular Ranibizumab and Bevacizumab in Transgenic Mice Expressing Human Vascular Endothelial Growth Factor
- (2009) Katsuaki Miki et al. OPHTHALMOLOGY
- Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1
- (2008) Carl D. Regillo et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Projection of Diabetic Retinopathy and Other Major Eye Diseases Among People With Diabetes Mellitus
- (2008) Jinan B. Saaddine ARCHIVES OF OPHTHALMOLOGY
- Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial
- (2008) L J Singerman et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- AAV-mediated gene therapy for retinal disorders: from mouse to man
- (2008) P K Buch et al. GENE THERAPY
- Gene Delivery of the Murine Equivalent of Bevacizumab (Avastin), an Anti-Vascular Endothelial Growth Factor Monoclonal Antibody, to Suppress Growth of Human Tumors in Immunodeficient Mice
- (2008) Masaki Watanabe et al. HUMAN GENE THERAPY
- Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial
- (2008) William W. Hauswirth et al. HUMAN GENE THERAPY
- Prolonged blockade of VEGF family members does not cause identifiable damage to retinal neurons or vessels
- (2008) Shinji Ueno et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Novel AAV serotypes for improved ocular gene transfer
- (2008) Corinna Lebherz et al. JOURNAL OF GENE MEDICINE
- Effect of Gene Therapy on Visual Function in Leber's Congenital Amaurosis
- (2008) James W.B. Bainbridge et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started